You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
界龍實業(600836.SH):擬3.2億元向關聯方收購五葉醫藥100%股權
格隆匯 05-21 18:26

格隆匯5月21日丨界龍實業(600836.SH)公佈,公司全資子公司易連生物工程(杭州)有限公司(簡稱“易連生物”)擬以人民幣現金方式收購關聯方杭州博贊豐新材料科技有限公司持有的哈爾濱五葉醫藥科技有限公司(簡稱“五葉醫藥)100%股權,交易金額為3.2億元。此次交易完成後,五葉醫藥將成為公司全資子公司。

博贊豐向易連生物保證並承諾,此次交易實施完畢後三年內(即2022年1月1日-2024年12月31日)五葉醫藥實際淨利潤額不低於相應期間的預測淨利潤額。以此次交易估值報吿中預測的承諾期內五葉醫藥每年合併口徑扣除非經常性損益歸屬母公司所有者的淨利潤為準。雙方確認,五葉醫藥2022年、2023年、2024年的預測淨利潤額分別為2700萬元、3400萬元和4000萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account